Latst News Archives - Page 2 of 2

ThermoGenesis, a Major Shareholder of Immunecyte, Announces that it has Notified the FDA of its Intent to Distribute the Company’s Rapid COVID-19 Point-of-Care Test Kit

by Immunecyte | Apr 3, 2020 | Latst News

RANCHO CORDOVA, Calif., March 31, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a major shareholder of Immunecyte, a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it has notified the U.S....

Recent Update on Coronavirus (COVID-19) Pandemic

by Immunecyte | Mar 26, 2020 | Latst News

RANCHO CORDOVA, Calif., March 24, 2020 — The current global pandemic of the coronavirus (COVID-19) has now affected more than 180 countries and regions, including over 40,000 cases in the United States alone. The disease has spread rapidly, leading to a tremendous...

Next Entries »

Han Ying

PHD, Director

25+ years of experience in cancer immunology. Extensive managerial experiences in Schering AG, Immunnova, Sanpower Group, Dendreon. Dr. Ying obtained his PhD from Stanford and trained with Dr. Steven Rosenberg at National Cancer Institute.

Michelle Zhu

Director

25+ year of R&D and managerial experience in stem cell and cell therapy industry. Ms. Zhu started her career in stem cell research at Harvard Medical School, and is now the President of ThermoGenesis Holdings Inc. (Nasdaq:THMO)

Gregg Solar

PhD | Head of Biology

25+ years of experience in cell therapy drug discovery and development. In-depth and extensive experiences in leading molecular & cell biology, cancer biology and cell therapeutic studies. Past experiences include STEMCELL Technology, Aastrom Biosciences (Nasdaq:ASTM) and Genetech.

Jody Patterson

Head of Quality

30+ years of experience as the head of quality assurance in medical field, including serving Director of Quality at Cord Blood Registry (CBR), one of the nation’s largest cord blood banks in the U.S.

Joseph Shen

MBA | Chief Operating and Marketing Officer

25+ year of managerial experience in business consulting and operation in healthcare insurance industry. Served as Consulting Partner at IBM for commercial healthcare sector. MBA from Indiana University.

Paul V. Holland

MD | Chief Medical Officer

40+ year of experience in years experiences with immunology, hematology and blood transfusion medicine.
Served as Chief Medical Directors at various public and private blood banks.

Michael Holder

MBA, CPA | Chief Financial Officer

Strategic financial executive with 25+ years of financial, transactional, and operational experience. Broad experience as CFO, CEO, Board Director, PE/VC Investor, and M&A professional of public and VC/PE backed Life Sciences, Healthcare, Medtech, and Technology companies. MBA from Wharton School of Business.

Chris Xu

PhD, MBA | Chief Executive Officer

20+ years R&D and managerial experiences in life sciences and pharmaceutical industry, including Pfizer and other public companies; advanced 20+ products into different stages of clinical trials; adjunct professor at Peking University. PhD in Immunology from Washington University in St. Louis, MBA from Emory University.